Home › Funds › Ratan Capital Management LP › INBX
Ratan Capital Management LP position in INBX
INHIBRX BIOSCIENCES INC · Health Care
Ratan Capital Management LP reported holding 16,000 shares of INBX (INHIBRX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 2.02% of its reported portfolio and ranking #11 among its reported holdings. Ratan Capital Management LP has disclosed INBX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Ratan Capital Management LP's INBX position evolved
Ratan Capital Management LP first disclosed a stake in INBX in Q2 2026 at 16,612 shares (US$1.6M). The position peaked in Q3 2026 at 16,000 shares, worth US$1.6M. Across 2 filings, Ratan Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 16,000 shares valued at US$1.6M — a reduction of -612 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 16.61K | $1.57M | New |
| Q3 2026 | 16.00K | $1.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INBX and 13F data
INBX (INHIBRX BIOSCIENCES INC) is a Health Care company. 41 other funds we track also report a position in INBX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$123.0M), Sanofi (US$115.9M), Schonfeld Strategic Advisors LLC (US$66.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INBX
- PERCEPTIVE ADVISORS LLC 1.30M sh · $122.96M · Q2 2026
- Sanofi 1.16M sh · $115.89M · Q3 2026
- Schonfeld Strategic Advisors LLC 697.59K sh · $66.10M · Q2 2026
- Sofinnova Investments, Inc. 391.62K sh · $39.19M · Q3 2026
- Parkman Healthcare Partners LLC 360.26K sh · $36.05M · Q3 2026
- PFM Health Sciences, LP 320.33K sh · $32.06M · Q3 2026
- First Turn Management, LLC 171.51K sh · $17.16M · Q3 2026
- Trails Edge Capital Partners, LP 170.00K sh · $17.01M · Q3 2026
More on Ratan Capital Management LP
FAQ
How long has Ratan Capital Management LP held INBX?
Ratan Capital Management LP has disclosed INBX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Ratan Capital Management LP's current position in INBX?
As of Q3 2026, Ratan Capital Management LP holds 16.00K shares of INBX (INHIBRX BIOSCIENCES INC), valued at $1.60M, representing 2.02% of its reported portfolio and ranking #11.
Has Ratan Capital Management LP been buying or selling INBX?
In the latest 13F filing (Q3 2026), Ratan Capital Management LP reduced its position in INBX. The position peaked in Q3 2026 at 16.00K shares.
Which other funds hold INBX?
Other major institutional holders of INBX include PERCEPTIVE ADVISORS LLC, Sanofi, Schonfeld Strategic Advisors LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.